Uracil

Uracil

SCHEMBL21385227

O=c1cc[nH]c(=O)[nH]1.P

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uracil SCHEMBL3798527 0.97 CRBN (1.00) —
Uracil SCHEMBL8235 0.97 — —
Uracil SCHEMBL5089507 0.97 — —
Uracil SCHEMBL16116311 0.94 — —
Uracil SCHEMBL2161716 0.94 — —
Uracil SCHEMBL8767625 0.94 — —
Uracil SCHEMBL2557975 0.94 — —
Uracil SCHEMBL18010636 0.94 — —
Uracil SCHEMBL4664232 0.94 CRBN (0.94) —
Uracil SCHEMBL710130 0.94 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182422-A1 NOVEL GENETICALLY MODIFIED NATURAL KILLER CELL LINE AND USE THEREOF 주식회사 에스엘바이젠 2019-09-26 — — WO claimed
CN-110520540-A Nucleic acid modification and identification methods IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBH 2019-11-29 — — CN disclosed
CN-110408580-A The method for producing the recombinant microorganism of cytimidine and producing cytimidine SUZHOU BIOSYNTHETICA INC 2019-11-05 — — CN disclosed
Send feedback